关键词：肾脏疾病;临床研究;治疗;患者;筛查;治疗;诊断;高血压;慢性肾脏疾病（CKD）
摘 要：A systematic review that included 110 reports of eligible studies published from January 1985 through January 2011 was undertaken to determine the potential benefits and adverse effects of screening, monitoring, and treatments for adults with chronic kidney disease (CKD) stages 13. CKD stages 13 are defined as: 1 (kidney damage with a glomerular filtration rate (GFR) >90 mL/min/1.73 m2), 2 (kidney damage with a GFR of 6089 mL/min/1.73 m2), or 3 (a GFR of 3059 mL/min/1.73 m2, regardless of kidney damage). The systematic review excluded studies of patients with CKD stages 4 and 5. This is a summary of the systematic review meant to assist in decisionmaking along with a patients values and preferences and should not be construed to represent clinical recommendations or guidelines.